__CONFIG_colors_palette__{"active_palette":0,"config":{"colors":{"62516":{"name":"Main Accent","parent":-1}},"gradients":[]},"palettes":[{"name":"Default Palette","value":{"colors":{"62516":{"val":"var(--tcb-skin-color-0)"}},"gradients":[]}}]}__CONFIG_colors_palette__
REGISTER YOUR INTEREST
__CONFIG_colors_palette__{"active_palette":0,"config":{"colors":{"62516":{"name":"Main Accent","parent":-1}},"gradients":[]},"palettes":[{"name":"Default Palette","value":{"colors":{"62516":{"val":"var(--tcb-skin-color-0)"}},"gradients":[]}}]}__CONFIG_colors_palette__
REGISTER NOW

Reconnect Safely

Quick and Scalable Testing Towards a Safe Singapore

In a post COVID-19 world, testing is key to move toward normalcy.

SpectraLIT™ enables fast and accurate COVID-19 on-site testing that can be deployed for mass gatherings, at malls, offices or event spaces.

Using first-of-its-kind spectrometer-on-a-chip combined with Machine Learning and Artificial Intelligence, SpectraLIT™ DETECTS AND ANALYSES COVID-19 VIRUS IN SECONDS - through oral mouth rinsing or nasal swab sampling - with a result accuracy comparable to a PCR test.

Unlike other COVID-19 testing methods, SpectraLIT™ offers minimal discomfort to patients, and with minimum resource allocation, allows pre-event testing to be done at different premises easily and effectively, with near instant results, hence enabling the surveillance required for control.

Clinical trials are currently ongoing. Please contact us for more information.

spectralit
spectralit

Reconnect Safely

Quick and Scalable Testing Towards a Safe Singapore

In a post COVID-19 world, testing is key to move toward normalcy.

SpectraLIT™ enables fast and accurate COVID-19 on-site testing that can be deployed for mass gatherings, at malls, offices or event spaces.

Using first-of-its-kind spectrometer-on-a-chip combined with Machine Learning and Artificial Intelligence, SpectraLIT™ DETECTS AND ANALYSES COVID-19 VIRUS IN SECONDS - through oral mouth rinsing or nasal swab sampling - with a result accuracy comparable to a PCR test.

Unlike other COVID-19 testing methods, SpectraLIT™ offers minimal discomfort to patients, and with minimum resource allocation, allows pre-event testing to be done at different premises easily and effectively, with near instant results, hence enabling the surveillance required for control.

Clinical trials are currently ongoing. Please contact us for more information.

spectralit

Reconnect Safely

Quick and Scalable Testing Towards a Safe Singapore

In a post COVID-19 world, testing is key to move toward normalcy.

SpectraLIT™ enables fast and accurate COVID-19 on-site testing that can be deployed for mass gatherings, at malls, offices or event spaces.

Using first-of-its-kind spectrometer-on-a-chip combined with Machine Learning and Artificial Intelligence, SpectraLIT™ DETECTS AND ANALYSES COVID-19 VIRUS IN SECONDS - through oral mouth rinsing or nasal swab sampling - with a result accuracy comparable to a PCR test.

Unlike other COVID-19 testing methods, SpectraLIT™ offers minimal discomfort to patients, and with minimum resource allocation, allows pre-event testing to be done at different premises easily and effectively, with near instant results, hence enabling the surveillance required for control.

Clinical trials are currently ongoing. Please contact us for more information.


Key Features

FAST - 1 SECOND SCAN

Result in less than xx seconds

RELIABLE

95% accuracy, comparable to PCR (Gold Standard)

SCALABLE

Require minimum space and investment

EASY-TO-DEPLOY

A 4 x 2 x 3 inch device

VERSATILE

Applications for virus testing beyond COVID-19

Resources

A newly developed saliva test aims to determine in less than a second whether or not you are infected with the novel coronavirus

A newly developed saliva test aims to determine in less than a second whether or not you are infected with the novel coronavirus

In a ground-breaking effort to keep international airports open and providing safe travel for both tourists and business executives in the COVID-19 era...

Newsight’s spectral technology, currently being tried on patients at Sheba Medical Center, could revolutionize SARS-CoV-2 testing across the world.